Medical marijuana has become increasingly popular in recent years, with more than two-thirds of the United States and the District of Columbia legalizing it for medical treatments. The FDA has only approved it for the treatment of two rare and serious forms of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. However, many people use marijuana to treat a variety of medical conditions, including the use of terpenes uk. In this article, we'll explore the uses of medical marijuana, possible side effects, and what research has been done on its effectiveness. Medical marijuana uses the marijuana plant or the chemicals it contains to treat diseases or conditions. It's basically the same product as recreational marijuana, but it's taken for medical purposes.
Cannabinoids, the active chemicals in medical marijuana, are similar to chemicals produced by the body that are involved in appetite, memory, movement and pain. Medical marijuana received a lot of attention a few years ago when parents said that a special form of the drug helped control seizures in their children. The FDA recently approved Epidiolex, which is made with CBD, as a treatment for people with very serious or difficult to treat seizures. In studies, some people experienced a dramatic decrease in seizures after taking this medication. Another problem is that the FDA doesn't oversee medical marijuana the way it does prescription drugs.
While states oversee and regulate sales, they often don't have the resources to do so. This means that the concentration and ingredients of medical marijuana can vary quite a bit depending on where you buy it. Last year we did a study where we bought labeled grocery products, such as brownies and lollipops, in California and Washington. “Then we sent them to the lab,” Bonn-Miller says. Few of the products contained anywhere near what they said they contained. Medical marijuana is used to relieve symptoms, not to treat or cure diseases.
It can relieve certain symptoms, make you feel better, and improve your quality of life. A small study suggests that CBD, a component of cannabis in many medical marijuana products, may not have much effect on driving or cognitive abilities. Research also states that people who smoke cannabis before the age of 18 are four to seven times more likely to develop a cannabis use disorder than adults. The committee did not identify a systematic review of good or good quality that would report on medical cannabis as an effective treatment for PTSD symptoms. The committee did not identify any good quality primary literature reporting on medical cannabis as an effective treatment for reducing depressive symptoms and that would be published after the data collection period of the most recently published good or good quality systematic review on the subject of research.
The committee did not identify any good quality primary literature reporting on medical cannabis as an effective treatment for the decreases in motor function and cognitive performance associated with Huntington's disease that would be published after the data collection period of the most recently published good or good quality systematic review that addressed the issue of research. There are certain states that offer more flexibility than others and that allow the use of medical cannabis for the treatment of any illness for which the drug alleviates the individual. The committee did not identify a systematic review of good or good quality reporting on medical cannabis as an effective treatment for symptoms associated with amyotrophic lateral sclerosis. The committee did not identify any good quality primary literature reporting on medical cannabis as an effective treatment for the improvement of anxiety symptoms, which was published after the data collection period of the most recently published good or good quality systematic review on the subject of research. Therefore, while the use of cannabis for the treatment of pain is supported by well-controlled clinical trials, as mentioned above, very little is known about the efficacy, dosage, routes of administration, or side effects of commonly used and commercially available cannabis products in the United States. The renewed interest in the therapeutic effects of cannabis comes from the movement that began 20 years ago to make cannabis available as a medicine for patients with various conditions. For chronic pain, most studies examined oral cannabis extract, although some examined smoked or vaporized cannabis.
In the first trials conducted at New York University's Langone Medical Center, medical marijuana extract showed a 50% reduction in the frequency of certain seizures in children and adults in a recent study with 213 patients. Given the continuing liberalization of cannabis laws, the number of these states is likely to increase and therefore support efforts to clarify the potential therapeutic benefits of medical cannabis in relation to various health outcomes. The committee did not identify any good quality primary literature reporting on medical cannabis as an effective treatment for symptoms of glaucoma and that would be published after the data collection period of the most recently published good or good quality systematic review on the subject of research.
